Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice Academic Article uri icon


MeSH Major

  • Bronchitis
  • Iron
  • Iron Chelating Agents
  • Iron-Binding Proteins
  • Lung
  • Mitochondria
  • Pulmonary Disease, Chronic Obstructive
  • Pulmonary Emphysema
  • Smoke
  • Tobacco


  • Chronic obstructive pulmonary disease (COPD) is linked to both cigarette smoking and genetic determinants. We have previously identified iron-responsive element-binding protein 2 (IRP2) as an important COPD susceptibility gene and have shown that IRP2 protein is increased in the lungs of individuals with COPD. Here we demonstrate that mice deficient in Irp2 were protected from cigarette smoke (CS)-induced experimental COPD. By integrating RNA immunoprecipitation followed by sequencing (RIP-seq), RNA sequencing (RNA-seq), and gene expression and functional enrichment clustering analysis, we identified Irp2 as a regulator of mitochondrial function in the lungs of mice. Irp2 increased mitochondrial iron loading and levels of cytochrome c oxidase (COX), which led to mitochondrial dysfunction and subsequent experimental COPD. Frataxin-deficient mice, which had higher mitochondrial iron loading, showed impaired airway mucociliary clearance (MCC) and higher pulmonary inflammation at baseline, whereas mice deficient in the synthesis of cytochrome c oxidase, which have reduced COX, were protected from CS-induced pulmonary inflammation and impairment of MCC. Mice treated with a mitochondrial iron chelator or mice fed a low-iron diet were protected from CS-induced COPD. Mitochondrial iron chelation also alleviated CS-induced impairment of MCC, CS-induced pulmonary inflammation and CS-associated lung injury in mice with established COPD, suggesting a critical functional role and potential therapeutic intervention for the mitochondrial-iron axis in COPD.


publication date

  • February 2016



  • Academic Article



  • eng

PubMed Central ID

  • PMC4742374

Digital Object Identifier (DOI)

  • 10.1038/nm.4021

PubMed ID

  • 26752519

Additional Document Info

start page

  • 163

end page

  • 74


  • 22


  • 2